Shares of Omega Healthcare Investors, Inc. ( NYSE:OHI – Get Free Report ) have been given an average recommendation of “Hold” by the twelve brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company.
The average 12 month target price among analysts that have covered the stock in the last year is $40.00. Several equities analysts have recently weighed in on OHI shares.
Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday.
Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 target price for the company.
Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th.
Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th.
Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Get Our Latest Analysis on Omega Healthcare Investors Omega Healthcare Investors Trading Up 0.
1 % Omega Healthcare Investors Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a dividend of $0.67 per share.
The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.
47%. Omega Healthcare Investors’s payout ratio is presently 197.06%.
Insider Transactions at Omega Healthcare Investors In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.
19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.
44. This represents a 0.00 % decrease in their position.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website . In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th.
The stock was sold at an average price of $40.19, for a total transaction of $905,962.98.
Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.
00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink . Also, COO Daniel J.
Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.
25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 0.
00 % decrease in their position. The disclosure for this sale can be found here . 1.
37% of the stock is owned by insiders. Institutional Inflows and Outflows Hedge funds have recently modified their holdings of the business. Versant Capital Management Inc bought a new stake in Omega Healthcare Investors in the second quarter worth $26,000.
UMB Bank n.a. raised its holdings in Omega Healthcare Investors by 353.
4% during the third quarter. UMB Bank n.a.
now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. acquired a new stake in shares of Omega Healthcare Investors in the third quarter worth about $33,000.
V Square Quantitative Management LLC boosted its stake in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 323 shares in the last quarter.
Finally, Covestor Ltd boosted its stake in shares of Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 431 shares in the last quarter.
Institutional investors and hedge funds own 65.25% of the company’s stock. About Omega Healthcare Investors ( Get Free Report Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.
Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S.
, as well as in the U.K. Featured Articles Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Omega Healthcare Investors, Inc. (NYSE:OHI) Receives $39.70 Consensus PT from Brokerages
Shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) have been given an average recommendation of “Hold” by the twelve brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month [...]